ATE383440T1 - Funktionalisierte eingekapselte fluoreszierende nanokristalle - Google Patents

Funktionalisierte eingekapselte fluoreszierende nanokristalle

Info

Publication number
ATE383440T1
ATE383440T1 AT01909283T AT01909283T ATE383440T1 AT E383440 T1 ATE383440 T1 AT E383440T1 AT 01909283 T AT01909283 T AT 01909283T AT 01909283 T AT01909283 T AT 01909283T AT E383440 T1 ATE383440 T1 AT E383440T1
Authority
AT
Austria
Prior art keywords
functionalized
fluorescent nanocrystals
encapsulated fluorescent
encapsulated
complexes
Prior art date
Application number
AT01909283T
Other languages
English (en)
Inventor
Emilio Barbera-Guillem
Original Assignee
Biocrystal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrystal Ltd filed Critical Biocrystal Ltd
Application granted granted Critical
Publication of ATE383440T1 publication Critical patent/ATE383440T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6818Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586Liposomes, microcapsules or cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989Microcapsule with solid core [includes liposome]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991Coated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991Coated
    • Y10T428/2993Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01909283T 2000-02-18 2001-02-16 Funktionalisierte eingekapselte fluoreszierende nanokristalle ATE383440T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18360800P 2000-02-18 2000-02-18
US18360700P 2000-02-18 2000-02-18
US09/783,469 US6761877B2 (en) 2000-02-18 2001-02-14 Functionalized encapsulated fluorescent nanocrystals

Publications (1)

Publication Number Publication Date
ATE383440T1 true ATE383440T1 (de) 2008-01-15

Family

ID=27391706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01909283T ATE383440T1 (de) 2000-02-18 2001-02-16 Funktionalisierte eingekapselte fluoreszierende nanokristalle

Country Status (6)

Country Link
US (3) US6761877B2 (de)
EP (1) EP1266032B1 (de)
AT (1) ATE383440T1 (de)
AU (1) AU2001237057A1 (de)
DE (1) DE60132311T2 (de)
WO (1) WO2001061045A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761877B2 (en) * 2000-02-18 2004-07-13 Biocrystal, Ltd. Functionalized encapsulated fluorescent nanocrystals
US20050059031A1 (en) * 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
EP2085781B2 (de) * 2000-10-06 2020-03-11 Life Technologies Corporation Zellen mit spektralen Signaturen und Verfahren zur Herstellung und Verwendung davon
JP2003028797A (ja) * 2001-07-11 2003-01-29 Hitachi Software Eng Co Ltd 蛍光読み取り装置
JP4072994B2 (ja) * 2001-10-11 2008-04-09 学校法人日本大学 磁性粒子
JP3955225B2 (ja) * 2002-03-27 2007-08-08 日立ソフトウエアエンジニアリング株式会社 半導体ナノ粒子を用いる反応の反応測定方法及び該測定方法を用いる半導体ナノ粒子の品質評価方法
JP3701622B2 (ja) 2002-03-27 2005-10-05 日立ソフトウエアエンジニアリング株式会社 半導体ナノ粒子蛍光試薬及び蛍光測定方法
JP3847677B2 (ja) 2002-07-23 2006-11-22 日立ソフトウエアエンジニアリング株式会社 半導体ナノ粒子、その製造方法、及び半導体ナノ粒子蛍光試薬
JP2004077389A (ja) * 2002-08-21 2004-03-11 Hitachi Software Eng Co Ltd 半導体ナノ粒子を含む機能性蛍光試薬
US20050032246A1 (en) * 2002-11-14 2005-02-10 Mcmaster University Method of immobilizing membrane-associated molecules
US8367324B2 (en) * 2003-11-17 2013-02-05 Canon Kabushiki Kaisha Method for judging change in probe-bearing substrate, probe-bearing substrate and detecting apparatus
JP4528990B2 (ja) * 2003-12-09 2010-08-25 学校法人慶應義塾 脂質二重膜とナノサイズ蛍光体複合体
GB0400235D0 (en) * 2004-01-07 2004-02-11 Univ Sunderland Nanoparticles as agents for imaging finger prints
US20060014175A1 (en) * 2004-05-17 2006-01-19 Imad Naasani Functionalized fluorescent nanocrystal detection system
US7794600B1 (en) * 2004-08-27 2010-09-14 Nanosys, Inc. Purification of nanocrystal solutions by chromatography
US8486371B2 (en) * 2004-09-17 2013-07-16 The Regents Of The University Of Michigan Quantitative two-photon flow cytometry
US20060240227A1 (en) * 2004-09-23 2006-10-26 Zhijun Zhang Nanocrystal coated surfaces
EP1809720B1 (de) * 2004-10-29 2012-05-02 Life Technologies Corporation Funktionalisierte fluoreszierende nanokristalle und verfahren zu deren herstellung und verwendung
WO2006084248A2 (en) * 2005-02-04 2006-08-10 Antigenics, Inc. Compositions comprising a platinum complex, lipid, and surfactant
GB2441666B (en) * 2005-04-25 2010-12-29 Univ Arkansas Doped semiconductor nanocrystals and methods of making same
JP5330828B2 (ja) 2005-08-09 2013-10-30 ユニヴァーシティ・オヴ・サンダーランド 疎水性シリカ粒子およびそれらの製造方法
US8101430B2 (en) 2005-08-15 2012-01-24 Massachusetts Institute Of Technology Fluorescent sensor based on two fluorescent moieties one of which is a semiconductor nanocrystal and methods of using and making
US8465983B1 (en) * 2005-08-19 2013-06-18 Gabriel P. Lopez Detection and delivery systems utilizing supported lipid bilayers
US20070134685A1 (en) * 2005-09-06 2007-06-14 Invitrogen Corporation Control of chemical modification
JP4415972B2 (ja) * 2005-09-22 2010-02-17 ソニー株式会社 金属酸化物ナノ粒子の製造方法
WO2007067257A2 (en) 2005-12-02 2007-06-14 Vanderbilt University Broad-emission nanocrystals and methods of making and using same
ES2798263T3 (es) 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
WO2008039912A2 (en) * 2006-09-27 2008-04-03 Evident Technologies Retro-emission systems comprising microlens arrays and luminescent emitters
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
FR2918755B1 (fr) * 2007-07-09 2009-10-30 Commissariat Energie Atomique Procede de detection et de quantification d'analytes sur support solide avec des molecules fluorescentes encapsulees dans des immunoliposomes.
US20090171330A1 (en) * 2007-12-28 2009-07-02 Spectranetics Tunable nanoparticle tags to enhance tissue recognition
US20090270269A1 (en) * 2008-04-28 2009-10-29 Ashok Kumar Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants
US20100090164A1 (en) * 2008-06-10 2010-04-15 Xiaogang Peng Indium arsenide nanocrystals and methods of making the same
US20120034156A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
US8895158B2 (en) 2011-08-10 2014-11-25 The Johns Hopkins University Nanoparticle taggants for explosive precursors
WO2013078252A1 (en) * 2011-11-22 2013-05-30 Qd Vision, Inc. Quantum dot-containing compositions including an emission stabilizer, products including same, and method
EP2841108A4 (de) * 2012-04-25 2015-11-25 Tufts College Seidenmikrokügelchen sowie verfahren zur oberflächenschmierung
WO2014085526A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
WO2014134338A1 (en) * 2013-03-01 2014-09-04 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Oligonucleotide functionalized quantum dots
US9229611B2 (en) * 2013-03-05 2016-01-05 Oracle International Corporation Automatic management of client data consistency
CN107072944B (zh) 2014-04-08 2021-11-02 阿拉迪姆公司 具有抗非结核分枝杆菌活性的脂质体环丙沙星制剂
CN106456551A (zh) 2014-04-08 2017-02-22 阿拉迪姆公司 冻融后形成药物纳米晶体的脂质体
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
WO2017147407A1 (en) * 2016-02-25 2017-08-31 Board Of Regents, The University Of Texas System Compositions comprising composite nanocarriers and methods of making and uses thereof
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
AU2019262117C1 (en) 2018-05-02 2024-12-05 Insmed Incorporated Methods for the manufacture of liposomal drug formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
WO1987007150A1 (en) * 1986-05-30 1987-12-03 The Johns Hopkins University Receptor-targeted drug delivery systems
CA1340806C (en) * 1986-07-02 1999-11-02 James Merrill Prober Method, system and reagents for dna sequencing
US5151507A (en) * 1986-07-02 1992-09-29 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
US5227489A (en) * 1988-08-01 1993-07-13 Ciba Corning Diagnostics Corp. Stable hydrophilic acridinium esters suitable for liposome encapsulation
US5578718A (en) * 1990-01-11 1996-11-26 Isis Pharmaceuticals, Inc. Thiol-derivatized nucleosides
US5187085A (en) * 1990-09-28 1993-02-16 Applied Biosystems, Inc. Nucleic acid sequence analysis with nucleoside-5'-o-(1-thiotriphosphates)
YU187991A (sh) * 1990-12-11 1994-09-09 Hoechst Aktiengesellschaft 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
US5364759B2 (en) * 1991-01-31 1999-07-20 Baylor College Medicine Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats
US5650277A (en) * 1992-07-02 1997-07-22 Diagenetics Ltd. Method of determining the presence and quantifying the number of di- and trinucleotide repeats
US6048616A (en) 1993-04-21 2000-04-11 Philips Electronics N.A. Corp. Encapsulated quantum sized doped semiconductor particles and method of manufacturing same
US5637258A (en) * 1996-03-18 1997-06-10 Nanocrystals Technology L.P. Method for producing rare earth activited metal oxide nanocrystals
EP1818417B1 (de) * 1996-07-29 2014-02-12 Nanosphere, Inc. Nanopartikel mit angehängten Oligonukleotiden und ihre Verwendungen
DE19724796A1 (de) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Mittel zur Antitumortherapie
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems
WO2000028089A1 (en) 1998-11-10 2000-05-18 Biocrystal Limited Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination
US6221602B1 (en) * 1998-11-10 2001-04-24 Bio-Pixels Ltd. Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination
US6194213B1 (en) * 1999-12-10 2001-02-27 Bio-Pixels Ltd. Lipophilic, functionalized nanocrystals and their use for fluorescence labeling of membranes
US6179912B1 (en) * 1999-12-20 2001-01-30 Biocrystal Ltd. Continuous flow process for production of semiconductor nanocrystals
US6761877B2 (en) * 2000-02-18 2004-07-13 Biocrystal, Ltd. Functionalized encapsulated fluorescent nanocrystals

Also Published As

Publication number Publication date
WO2001061045A1 (en) 2001-08-23
DE60132311D1 (de) 2008-02-21
DE60132311T2 (de) 2009-01-02
EP1266032B1 (de) 2008-01-09
US7244413B2 (en) 2007-07-17
EP1266032A1 (de) 2002-12-18
US20060099147A1 (en) 2006-05-11
EP1266032A4 (de) 2005-01-19
US6761877B2 (en) 2004-07-13
US20050019486A1 (en) 2005-01-27
AU2001237057A1 (en) 2001-08-27
US20020001716A1 (en) 2002-01-03
US7060252B2 (en) 2006-06-13

Similar Documents

Publication Publication Date Title
ATE383440T1 (de) Funktionalisierte eingekapselte fluoreszierende nanokristalle
DE60234382D1 (de) Nanokristalle
WO2001053822A3 (de) Verfahren und einrichtung zur bestimmung temperaturabhängiger parameter
ATE317122T1 (de) Fluoreszierende polarisation
AU3659002A (en) Methods, circuits and compositions of matter for in vivo detection of biomolecule concentrations using fluorescent tags
DE69735532D1 (de) Bestimmung von antigenen mittels oligonukleotid-antikörper-konjugaten
WO2000027365A8 (en) Functionalized nanocrystals and their use in detection systems
JP2005513471A5 (de)
ATE409238T1 (de) Nachweis der hybridisierung von nukleinsäuren durch fluoreszenzpolarisation
DE69635801D1 (de) Prostataspezifisches membranes antigen und seine anwendungen
AU2002230419A1 (en) Fluorescence and fret based assays for biomolecules on beads
WO2002059253A3 (en) Fluorescence detection system including a photonic band gap structure
AU7532501A (en) Method for increasing luminescence assay sensitivity
ATE487935T1 (de) Fluorometer
DE69604920D1 (de) Verwendung einer phycobiliprotein-peptidkomplexverbindung als fluoreszenzlabel
WO2001073443A3 (en) Methods and compositions for the simultaneous detection of multiple analytes
DE60114804D1 (de) Konstruierte fluoreszenzproteine mit langen wellenlängen
DE60222091D1 (de) Dendritische chemilumineszierende Substrate
DE69924147D1 (de) Floureszenzintensitäts-test für eine protein- oder peptidbindung an nukleinsäuren
DE69732034D1 (de) Assay-verfahren
ATE336572T1 (de) Neuen reagenzien in chemilumineszenz- nachweisverfahren
NO20052553L (no) Cobalaminanalyse.
WO2006073563A3 (en) Fluorescent affinity tag to enhance phosphoprotein detection
DK0871764T3 (da) Screeningsfremgangsmåde
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1266032

Country of ref document: EP

REN Ceased due to non-payment of the annual fee